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Abstract
Standard logistic regression analysis of case-control data has low power to detect gene-
environment interactions, but until recently it was the only method that could be used
on complex polygenic data for which parametric distributional models are not feasible.
Under the assumption of gene-environment independence in the underlying population,
Stalder et al. (2017, Biometrika, 104, 801-812) developed a retrospective method that treats
both genetic and environmental variables nonparametrically. However, the mathematical
symmetry of genetic and environmental variables is overlooked. We propose an improve-
ment to the method of Stalder et al. that increases the efficiency of the estimates with
no additional assumptions and modest computational cost. This improvement is achieved
by treating the genetic and environmental variables symmetrically to generate two sets of
parameter estimates that are combined to generate a more efficient estimate. We employ
a semiparametric framework to develop the asymptotic theory of the estimator, and eval-
uate its performance via simulation studies. The method is illustrated using data from a
case-control study of breast cancer.
Some Key Words: Gene-environment interaction; Case-control study; Genetic epidemiol-
ogy; Semiparametric estimation; Biased samples.
Short title: Semiparametric Analysis of Gene-Environment Interactions
1 Introduction
Genetic epidemiologists have identified both genetic and environmental factors that influence
the incidence of complex diseases such as cancers, heart diseases, depression, and diabetes
(Gustavsson et al., 2016; Krischer et al., 2017; Mullins et al., 2016; Nickels, 2013; Rudolph,
2015). As new studies identify additional genetic variants associated with a disease, attention
turns to exploring the interaction between genetic susceptibility and environmental risk
factors.
Researchers studying gene-environment interactions often adopt a case-control study de-
sign, wherein diseased cases and healthy control subjects are identified and their covariate
information is collected retrospectively. When the disease is rare, sampling cases and con-
trols separately provides substantial cost and time savings over a prospective cohort study,
but it makes statistical inference more complicated.
Prentice and Pyke (1979) demonstrated that standard prospective logistic regression of
case-control data, which ignores the retrospective sampling scheme, nevertheless yields con-
sistent estimates of all parameters except the logistic intercept. Logistic regression is equiva-
lent to maximum likelihood estimation under a model that places no assumptions on the joint
distribution of the genetic and environmental variables, and it achieves the variance lower
bound under this model (Breslow et al., 2000). However, logistic regression of case-control
data lacks power to detect gene-environment interaction effects.
To improve estimation efficiency, studies of gene-environment interactions often take ad-
vantage of the relatively mild assumption that the genetic and environmental variables are
independently distributed in the source population. This assumption is easy to test, is fre-
quently valid, and enables the use of specialized methods for the analysis of case-control
data. Piegorsch et al. (1994) proposed a case-only approach that efficiently estimates multi-
plicative interactions (but not main effects) under the assumptions of gene-environment in-
dependence and rare disease. Chatterjee and Carroll (2005) exploited the gene-environment
independence assumption to develop a semiparametric retrospective profile likelihood frame-
work that treats environmental variables nonparametrically but assumes that the genetic
variables have a known, discrete distribution. Further developments have yielded additional
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retrospective methods based on parametric modeling of the distribution of genetic variables
given the environmental variables, see for example Han et al. (2012); Liang et al. (2019);
Lobach et al. (2008); Ma (2010).
Genome-wide association studies have shown that genetic predisposition to a single
disease tends to be highly polygenic, with many genetic variants influencing disease risk
(Chatterjee et al., 2016; Fuchsberger et al., 2016). To provide a more complete picture of
genetic risk and gene-environment interactions, it is often advantageous to include multi-
ple genetic loci in the disease model (Chatterjee et al., 2006; Jiao et al., 2013; Lin et al.,
2015). In the interest of parsimony, many studies have focused on developing polygenic
risk scores through a weighted combination of all known genetic variants associated with
a disease (Chatterjee et al., 2013; Dudbridge, 2013). Handling multiple genetic variants,
polygenic risk scores, or a combination of both is straightforward with prospective logistic
regression, but can be unwieldy or even impossible when using retrospective methods that
exploit gene-environment independence to gain efficiency but require a parametric model for
the distribution of the genetic component.
The method of Stalder et al. (2017) extends the Chatterjee-Carroll retrospective profile
likelihood framework by treating both the genetic and environmental variables nonpara-
metrically, requiring only the assumption of gene-environment independence in the source
population. This assumption of independence can be weakened if a discrete stratification
variable is found such that genes and environment are independent within strata of the source
population. However, Stalder et al. (2017) overlooked the mathematical symmetry of the ge-
netic and environmental variables in the retrospective likelihood, resulting in a sub-optimal
efficiency gain.
With this valuable discovery, here we propose an improvement to the method of
Stalder et al. (2017) that substantially increases the efficiency of the estimates with no
additional assumptions and modest computational cost. This development relies on the
observation that the method of Stalder et al. removes dependence on the distribution of the
genetic and environmental variables in two different fashions; by treating the genetic and
environmental variables symmetrically we generate two sets of parameter estimates that are
combined to generate a more efficient estimate. We employ a semiparametric framework
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to develop the asymptotic theory of the estimator. The properties of the new method are
illustrated through simulations in Section 3, and an example in Section 4.
2 Methodology and Theory
2.1 Background
We adopt notation similar to that of Stalder et al., with disease status, genetic information,
and environmental risk factors denoted by D, G, and X , respectively. Both G and X are
potentially multivariate and can contain both discrete and continuous components. For a
given case-control study, n1 is the number of cases (D = 1) and n0 is the number of controls
(D = 0), while π1 = pr(D = 1) is the disease rate in the source population and π0 = 1− π1.
We maintain the assumption in Stalder et al. that π1 is either known or can be estimated
well.
The assumption of gene-environment independence in the source population can be writ-
ten as fGX(g, x) = fG(g)× fX(x), where fGX(·, ·) is the joint density or mass of G and X in
the underlying population, and fG(·) and fX(·) are the marginal density or mass functions
of G and X , respectively, in the underlying population. We assume fX(x) and fG(g) are
completely unspecified.
Given the genetic and environmental covariates, we assume the risk of disease in the
underlying population follows the model pr(D = 1 | G,X) = H{α0 + m(G,X,β)}, where
H(x) = {1 + exp(−x)}−1 is the logistic distribution function and m(G,X,β) is a function
that describes the joint effect of G and X and is known up to the unspecified parameters of
interest β.
Given the subject’s disease status, the retrospective likelihood is the probability of ob-
serving the genetic and environmental variables. Under gene-environment independence in
the source population, the retrospective likelihood is
fG(g)fX(x) exp[d{α0 +m(g, x, β)}]/[1 + exp{α0 +m(g, x, β)}]∫
fG(u)fX(v) exp[d{α0 +m(u, v, β)}]/[1 + exp{α0 +m(u, v, β)}]dudv
.
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The logistic intercept α0, typically of little scientific interest, is not consistently estimated
using prospective logistic regression, which instead converges to κ = α0 + log(n1/n0) −
log(π1/π0) (Prentice and Pyke, 1979). For convenience, we parameterize everything in terms
of κ, and we define Ω = (κ,βT)T. Chatterjee and Carroll (2005) profiled out fX(·) to create
a semiparametric profile likelihood
LX(D,G,X,Ω, fG) = fG(G)
S(D,G,X,Ω)
RX(X,Ω)
, (1)
where
S(d, g, x,Ω) =
exp[d{κ+m(g, x, β)}]
1 + exp{κ− log(n1/n0) + log(π1/π0) +m(g, x, β)}
;
RX(x,Ω) =
∑1
r=0
∫
fG(v)S(r, v, x,Ω)dv. (2)
The key insight of Stalder et al. (2017) was to develop an unbiased estimator of RX(x,Ω)
that treats fG(·) nonparametrically, defined as
R̂X(x,Ω) =
∑n
j=1
∑1
r=0
∑1
d=0(πd/nd)I(Dj = d)S(r, Gj, x,Ω). (3)
The leading term fG(G) in eq. (1) is constant with respect to Ω, and can be ignored for the
purpose of estimation. Replacing RX(x,Ω) with R̂X(x,Ω) and taking the logarithm yields
the estimated profile loglikelihood of Ω given the data as
L̂X(Ω) =
∑n
i=1log{S(Di, Gi, Xi,Ω)} −
∑n
i=1log{R̂X(Xi,Ω)}. (4)
Define SΩ(d, g, x,Ω) = ∂S(d, g, x,Ω)/∂Ω and R̂XΩ(x,Ω) = ∂R̂X(x,Ω)/∂Ω. The profile
likelihood score function, SX(Ω), is unknown but can be estimated consistently by
ŜX(Ω) = n
−1/2
n∑
i=1
{
SΩ(Di, Gi, Xi,Ω)
S(Di, Gi, Xi,Ω)
−
R̂XΩ(Xi,Ω)
R̂X(Xi,Ω)
}
. (5)
By solving ŜX(Ω) = 0, we obtain a consistent estimate of Ω, which we will denote as Ω̂X
and which is called the SPMLE by Stalder et al. (2017).
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2.2 Symmetric Combination Estimator
The above equations are equivalent to those found in Stalder et al. (2017) with the addition
of the subscript X in eqs. (1) to (5) to emphasize that the density of X has been profiled
out, leaving the density of G to be treated nonparametrically. Because our only assumption
about G and X is their independence in the source population, we could just as well have
interchanged them and profiled out the distribution of G. The notation in this symmetric
case is analogous to the above, but with subscript G instead of X . It follows that the
analogous estimated score function
ŜG(Ω) = n
−1/2
n∑
i=1
{
SΩ(Di, Gi, Xi,Ω)
S(Di, Gi, Xi,Ω)
−
R̂GΩ(Gi,Ω)
R̂G(Gi,Ω)
}
can be used to obtain Ω̂G, another consistent estimate of Ω.
The optimal combination of symmetric estimators Ω̂X and Ω̂G follows the principle of
generalized least squares. Suppose the dimension of Ω is p. Let Ip be the p × p identity
matrix and define X = (Ip, Ip)
T. Define Y = (Ω̂TX , Ω̂
T
G)
T and Λall = cov(Y). Theorem 1, in
Section 2.3, shows Y → Normal(XΩ,Λall).
Treating this as a generalized least squares problem, we can rewrite it as Y = XΩ + ǫ,
where ǫ ∼ Normal(0,Λall). The Symmetric Combination Estimator is the solution to the
linear model, namely
Ω̂Symm = (X
TΛ−1allX )
−1XTΛ−1allY . (6)
An alternative method of combining the two estimates is to average the two estimated
profile likelihoods into a single composite likelihood. The resulting Composite Likelihood Es-
timator yields minimal efficiency gains over the SPMLE from Stalder et al., and is presented
in Section S.1 of the Supplementary Material .
2.3 Asymptotic Theory
In this subsection we first demonstrate that the joint distribution of Ω̂X and Ω̂G is asymp-
totically normal. We then show the asymptotic results for the Symmetric Combination
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Estimator. In practice, asymptotic standard errors for the Symmetric Combination Esti-
mator proved unreliable due to slow convergence, so bootstrap standard errors are used
instead.
To state the asymptotic results, let Zi = (Di, Gi, Xi) then define
ΓX =
1∑
d=0
nd
n
E
[
∂
∂ΩT
{
SΩ(Z,Ω)
S(Z,Ω)
−
RXΩ(X,Ω)
RX(X,Ω)
} ∣∣∣∣D = d] ;
ΓG =
1∑
d=0
nd
n
E
[
∂
∂ΩT
{
SΩ(Z,Ω)
S(Z,Ω)
−
RGΩ(X,Ω)
RG(X,Ω)
} ∣∣∣∣D = d] ;
ζX(Zi,Ω) =
SΩ(Zi,Ω)
S(Zi,Ω)
−
RXΩ(Xi,Ω)
RX(Xi,Ω)
−
1∑
d=0
1∑
r=0
ndπdi
ndi
E
{
SΩ(r, g,X,Ω)
RX(X,Ω)
−
RXΩ(X,Ω)S(r, g,X,Ω)
R2X(X,Ω)
∣∣∣∣D = d}
g=Gi
;
ζG(Zi,Ω) =
SΩ(Zi,Ω)
S(Zi,Ω)
−
RGΩ(Gi,Ω)
RG(Gi,Ω)
−
1∑
d=0
1∑
r=0
ndπdi
ndi
E
{
SΩ(r, G, x,Ω)
RG(G,Ω)
−
RGΩ(G,Ω)S(r, G, x,Ω)
R2G(G,Ω)
∣∣∣∣D = d}
x=Xi
;
ζX∗(Zi,Ω) = ζX(Zi,Ω)−E{ζX(Z,Ω)|D = Di};
ζG∗(Zi,Ω) = ζG(Zi,Ω)−E{ζG(Z,Ω)|D = Di}.
By profiling X and G out separately, we have the following two equations
n1/2(Ω̂X − Ω) = −Γ
−1
X n
−1/2
∑n
i=1ζX∗(Zi,Ω) + op(1); (7)
n1/2(Ω̂G − Ω) = −Γ
−1
G n
−1/2∑n
i=1ζG∗(Zi,Ω) + op(1). (8)
Equation (7) is proved in Theorem 1 of Stalder et al. (2017), and the proof of the symmetric
case in eq. (8) is analogous.
To demonstrate the asymptotic properties of the Symmetric Combination Estimator,
denote the block-diagonal matrix Γ−1all = diag(Γ
−1
X ,Γ
−1
G ).
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Theorem 1 Suppose that 0 < lim
n→∞
nd/n < 1, and π1 is known. Then
n1/2(Y − XΩ) = −Γ−1all n
−1/2
n∑
i=1
ζX∗(Zi,Ω)ζG∗(Zi,Ω)
+ op(1).
The Zi are independent and E{ζX∗(Zi,Ω)|Di} = E{ζG∗(Zi,Ω)|Di} = 0, so as n→∞,
n1/2(Y − XΩ)→ Normal(0,Λall) (9)
in distribution, where
Λall = Γall Σall Γ
T
all;
Σall = cov
ζX∗(Z,Ω)ζG∗(Z,Ω)
 = cov
ζX(Z,Ω)ζG(Z,Ω)
 .
The proof of Theorem 1 follows directly from the proofs of eqs. (7) and (8) and the
properties of M-estimators Ω̂X and Ω̂G.
Remark 1 In Section 2.2, we constructed a linear model from eq. (9) and used generalized
least squares to calculate Ω̂Symm. The asymptotic properties of GLS estimators inform us
that as n→∞,
n1/2(Ω̂Symm − Ω)→ Normal{0, (X
TΛ−1allX )
−1}.
In practice, Ω̂X and Ω̂G are highly correlated, which slows convergence to the asymptotic
covariance matrix. Asymptotic estimates of standard errors proved unreliable in simulations,
and are not recommended. Instead, we estimate cov(Ω̂Symm) using a balanced bootstrap, where
cases and controls are resampled separately, thus maintaining their respective sample sizes.
2.4 Rare Diseases When π1 is Unknown
Due to its sampling efficiency, the case-control design is typically used to study relatively rare
diseases. If the true disease rate in the source population is unknown, it is common to assume
that π1 ≈ 0 (Kwee et al., 2007; Lin and Zeng, 2006; Modan et al., 2001; Piegorsch et al.,
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1994). Under this rare disease assumption, Ω̂X and Ω̂G converge not to Ω, but to ΩX∗ and
ΩG∗, the solutions to their respective score equations with π1 = 0. Using estimates of ΩX∗ and
ΩG∗ to calculate Ω̂Symm runs the risk of introducing bias, but in practice the small potential
bias is typically inconsequential unless the sample size is very large and standard errors
unusually small. Examples in Section S.2.2 of the Supplementary Material demonstrate that
under the rare disease approximation, coverage intervals remain near nominal until the true
disease rate exceeds 8%.
3 Simulations
3.1 Scenario
To investigate the performance of the Symmetric Combination Estimator, we adopt the
same simulation settings as reported in Stalder et al. (2017). Environmental variable X is
binary with population frequency 0.5, and G consists of five correlated single nucleotide
polymorphisms (SNPs). The SNPs follow a trinomial distribution in Hardy-Weinberg equi-
librium, wherein SNP Gj takes values (0, 1, 2) with probabilities {(1−pj)
2, 2pj(1−pj), p
2
j},
respectively.
To generate correlated SNPs, we first simulated a 5-variate normal random variable with
mean 0 and covariance between the jth and kth components equal to 0.7|j−k|. We then
trichotomized the variates with appropriate thresholds so that the frequency of 0, 1, and
2 followed Hardy-Weinberg equilibrium with minor allele frequencies (p1, p2, p3, p4, p5) =
(0.1, 0.3, 0.3, 0.3, 0.1).
Disease status was simulated according to the risk model H{α0 + m(G,X,β)}, with
m(G,X, β) = GTβG+XβX+(GX)
TβGX . Here βG = {log(1.2), log(1.2), 0, log(1.2), 0}, βX =
log(1.5), and βGX = {log(1.3), 0, 0, log(1.3), 0}. We set the logistic intercept α0 = −4.165 to
yield a population disease rate π1 = 0.03.
A sample of 1000 cases and 1000 controls was drawn from the simulated population, and
parameters were estimated using logistic regression, the SPMLE of Stalder et al. (2017),
the Symmetric Combination Estimator with known π1, and the Symmetric Combination
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Estimator with a rare disease approximation. Standard error estimates for both logistic
regression and the SPMLE were based on asymptotic theory, while those for the Symmetric
Combination Estimator were calculated using 200 balanced bootstrap samples, as described
in Remark 1.
3.2 Results
Table 1 presents the results of 1000 simulations comparing standard logistic regression, the
SPMLE proposed by Stalder et al. with known π1, our proposed Symmetric Combination
Estimator with known π1, and the Symmetric Combination Estimator using the rare disease
approximation. Standard error estimates for logistic regression and the SPMLE were cal-
culated using asymptotic theory, and the standard error estimates for both versions of the
Symmetric Combination Estimator were calculated using 200 bootstrap samples as described
in Remark 1.
The Symmetric Combination Estimator, both with known π1 and when using the rare
disease approximation, shows negligible bias and has coverage percentages near the nominal
level. Like the SPMLE, both versions of our Symmetric Combination Estimator provide
slightly more than 25% improvement in mean squared error efficiency over ordinary logistic
regression for the main effect of X .
More impressively, our estimator nearly doubles the mean squared error efficiency of lo-
gistic regression for the main effects of G, and nearly triples the mean squared error efficiency
for the interaction terms. This is a marked improvement even over the performance of the
SPMLE, and it is accomplished without modeling the distribution of either G or X .
3.3 Further Simulations
Further simulations were conducted with multiple correlated SNPs and a binary environ-
mental risk factor, but with changes to the number of SNPs (3 or 8), the population disease
rate (1% or 5%), or the sample size (500 or 3000 cases & controls). All such simulations
yielded results similar to those in Table 1 with regards to coverage, efficiency gains, and
unbiasedness, and are thus not reported.
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Table 1: Results of 1000 simulations as described in Section 3.1, comparing the bias,
coverage, and efficiency of four estimators: ordinary logistic regression, the SPMLE of
Stalder et al. with known π1, our proposed Symmetric Combination Estimator with
known π1, and the Symmetric Combination Estimator using the rare disease approxi-
mation
βG1 βG2 βG3 βG4 βG5 βX βXG1 βXG2 βXG3 βXG4 βXG5
True 0.18 0.18 0.00 0.18 0.00 0.41 0.26 0.00 0.00 0.26 0.00
Logistic Regression
Bias 0.01 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00
CI(%) 95.2 95.5 94.4 94.7 95.3 95.8 94.5 95.9 94.7 94.6 95.3
SPMLE, known π1
Bias 0.01 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.01
CI(%) 95.4 95.8 94.8 96.1 96.3 95.6 94.6 96.0 94.3 95.6 95.1
MSE Eff All G: 1.29 1.27 All G∗X : 1.98
Symmetric Combination Estimator, known π1
Bias 0.00 -0.03 0.00 0.00 -0.01 0.01 -0.03 0.02 0.00 -0.02 0.01
CI∗(%) 96.7 95.7 96.7 96.5 97.8 95.4 94.8 96.7 96.2 96.6 97.2
MSE Eff All G: 1.92 1.31 All G∗X : 2.90
Symmetric Combination Estimator, rare
Bias 0.01 -0.02 0.00 0.01 -0.01 0.02 -0.05 0.02 0.00 -0.03 0.00
CI∗(%) 96.4 95.7 95.7 96.3 98.1 94.9 94.0 97.0 96.4 95.5 97.5
MSE Eff All G: 1.86 1.27 All G∗X : 2.96
CI : coverage of a 95% nominal confidence interval, calculated using asymptotic standard error.
CI∗: coverage of a 95% nominal confidence interval, calculated using 200 bootstrap samples.
MSE Eff : mean squared error efficiency when compared to logistic regression, averaged over G
(All G) or G∗X interactions (All G∗X).
Section S.2 of the Supplementary Material contains the results of simulations examining
the behavior of the Symmetric Combination Estimator in a variety of settings. Section S.2.1
contains an unabridged version of Table 1 that includes the SPMLE G (Ω̂G) and the Com-
posite Likelihood Estimator, neither of which approach the MSE efficiency of the Symmetric
Combination Estimator. Section S.2.2 presents the results of simulations with misspecified
population disease rate; we found the Symmetric Combination Estimator fairly robust to the
misspecification of the disease rate. Section S.2.3 contains simulation studies examining the
robustness of our method with respect to violations of the gene-environment independence
assumption. Those simulations demonstrate that there will be bias in the estimated interac-
tion parameter between a specific gene and a correlated environmental variable, but the rest
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of the parameter estimates continue unbiased, and the average mean squared error for all
G∗X interactions can still be substantially lower than that obtained from prospective logistic
regression. Section S.2.4 presents the results of simulations with different distributions for
G and X .
4 Data Analysis
4.1 Data
Here we apply the proposed methodology to a case-control study of breast cancer. This case-
control sample is taken from a large prospective cohort at the National Cancer Institute: the
Prostate, Lung, Colorectal and Ovarian cancer screening trial (Canzian et al., 2010). This
cohort enrolled 64,440 non-Hispanic, white women aged 55 to 74, of whom 3.72% developed
breast cancer (Pfeiffer et al., 2013). The case-control study analyzed here consists of 658
cases and 753 controls.
Each of the 1411 subjects was genotyped for 21 SNPs that have been previously associ-
ated with breast cancer based on large genome-wide association studies. These SNPs were
weighted by their log-odds-ratio coefficients and summed to define a polygenic risk score. A
scaled version of this polygenic risk score, with mean zero and standard deviation one, was
used as the genetic risk factor G. The individual SNPs and their coefficients can be found
in Section S.2.5 of the Supplementary Material .
Early menarche is a known risk factor for breast cancer (Anderson et al., 2007), and
environmental variable X is a binary indicator of whether the age at menarche is less than
14. The interaction between age at menarche and genetic breast cancer risk is a topic of
interest, but the power to detect such interactions in previous studies has been limited (Gail,
2008).
The model fitted is pr(D = 1) = H(β0 + βGG + βXX + βGXGX). While π1 is known
in this population, we apply our method using both the known disease rate and the rare
disease approximation.
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4.2 Verifying Gene-Environment Independence
Before applying our approach, we performed analyses to check the assumption of gene-
environment independence in the population. Using the 753 controls, we ran a t-test of the
polygenic risk score against the levels of X . The p-value was 0.91, indicating no evidence of
correlation between G and X . We also ran chi-squared tests for each of the 21 individual
genes and found no significant association after controlling the false discovery rate: the
minimum q-value was 0.09.
We also checked for correlation, known as linkage disequilibrium, between the 21 SNPs
used to create the polygenic risk score and 32 SNPs known to influence age at menarche
(Elks et al., 2010). Using phased haplotypes from subjects of European descent from 1000
Genomes (Consortium, 2015) and HapMap (Gibbs et al., 2003), we were able to analyze
651 of the 672 possible linkages, and no evidence of linkage disequilibrium was found: the
maximum R2 was 0.1 and the minimum q-value was 0.85. Finally, a recent study of breast
cancer susceptibility loci examined the relationship between age at menarche and 10 of the
21 SNPs used to create our polygenic risk score, none of which were found to influence age
at menarche (Andersen et al., 2014).
4.3 Results
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Table 2: Results of the analysis of the Prostate, Lung, Colorectal and Ovarian
cancer screening trial data
βG βX βGX
Logistic Regression
Estimate 0.539 0.124 -0.242
Standard Error (asymptotic) 0.117 0.128 0.133
p-value (asymptotic) < 1e-4 0.331 0.068
Symmetric Combination, known π1 = 3.72%
Estimate 0.495 0.093 -0.215
Standard Error (bootstrap) 0.094 0.133 0.089
p-value (bootstrap) < 1e-4 0.484 0.016
SPMLE, known π1 = 3.72%
Estimate 0.587 0.127 -0.274
Standard Error (asymptotic) 0.103 0.128 0.108
p-value (asymptotic) < 1e-4 0.321 0.011
Symmetric Combination, rare disease approximation
Estimate 0.538 0.116 -0.237
Standard Error (bootstrap) 0.089 0.124 0.099
p-value (bootstrap) < 1e-4 0.352 0.016
SPMLE, rare disease approximation
Estimate 0.590 0.129 -0.269
Standard Error (asymptotic) 0.104 0.128 0.106
p-value (asymptotic) < 1e-4 0.315 0.012
βG and βX are the main effects for the polygenic risk score G and the environmental
variable X (age at menarche < 14), and βGX is the gene-environment interaction.
Table 2 presents the results of our analysis with known π1 and under a rare disease ap-
proximation. In both cases, standard errors for the Symmetric Combination Estimator were
calculated using 500 bootstrap samples. The two estimates yield very similar results, in-
dicating that a valid analysis can be conducted even if π1 is not known. The p-value for
SPMLE estimates are smaller, due to the larger estimates compared to Symmetric Combina-
tion Estimator. However, the Symmetric Combination Estimator often has smaller standard
error, especially for the gene-environment interaction term.
The polygenic risk score was strongly associated with breast cancer status of the women
in the study, which is to be expected given that each of its component SNPs has a known
association with breast cancer risk. Standard logistic regression analysis provides some
indication of an interaction between the polygenic risk score and age at menarche, but
the result is not statistically significant at the 0.05 level. Using the assumption of gene-
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environment independence in the population, the Symmetric Combination Estimator finds
stronger evidence of this interaction. The improved power to detect this interaction is due to
the much smaller standard error estimates of the Symmetric Combination Estimators. Using
logistic regression, the estimated standard error of βGX is 49% larger than with our method,
indicating a variance increase of 121% (when applying the rare disease approximation, the
variance increase is 81%).
5 Discussion and Extensions
Researchers investigating gene-environment interactions in case-control studies have tradi-
tionally had two broad options for analysis: standard logistic regression, which is flexible
but has low power to detect interactions, or retrospective methods, which lack flexibility but
offer improved efficiency by exploiting the assumption of gene-environment independence.
Improved understanding of genetic risk factors has led to the need for efficient estimators
that can model complex gene-environment interactions. Stalder et al. (2017) proposed a ret-
rospective profile method that exploits the assumption of gene-environment independence
while treating the genetic and environmental variables nonparametrically. By obviating the
need for a parametric model of genotype distributions, their method is well suited for the
analysis of multimarker genetic data and polygenic risk scores.
We observed the mathematical symmetry of the genetic and environmental variables and
discovered the sub-optimal efficiency gain in Stalder et al. (2017). Hence, we proposed an
improvement to the method of Stalder et al. (2017) that substantially increases the efficiency
of the estimates with modest computational cost and no additional assumptions, making it
applicable anywhere that the method of Stalder et al. can be used. Simulations under a
variety of scenarios demonstrate a consistent improvement in mean squared error efficiency
over the method of Stalder et al. (2017) and logistic regression on the estimation of both
main effects and gene-environment interaction terms. Our methods are implemented in the
R package caseControlGE, freely available at github.com/alexasher/caseControlGE.
The proposed Symmetric Combination Estimator places no distributional assumptions
on the genetic or environmental variables, but it does rely on three assumptions. The first
14
assumption, that the logistic risk model H{α0+m(G,X,β)} is known up to parameters α0
and β, is minimally restrictive because a flexible function, such as a function of B-splines,
can be defined for m(G,X,β). The second assumption, that π1 is known or can be well
estimated, can be relaxed by using the rare disease approximation of Section 2.4. Even if the
true disease rate is not rare, the Symmetric Combination Estimator is generally robust to
the misspecification of π1, as demonstrated in Section S.2.2 of the Supplementary Material .
The final assumption is gene-environment independence in the source population. In
Section S.2.3 of the Supplementary Material , we present the results of simulations demon-
strating that bias is introduced in the estimated interaction parameter between correlated
genetic and environmental variables, but the rest of the parameter estimates are unbiased.
We recommend that researchers verify gene-environment independence before applying the
Symmetric Combination Estimator, as we did in Section 4.2. To relax the gene-environment
independence assumption, it should be straightforward to adapt the Symmetric Combination
Estimator to the case where G and X are conditionally independent within the strata of an
observed factor, as demonstrated in the Supplementary Material of Stalder et al. (2017). If
suitable strata cannot be found, another possibility is to construct an empirical Bayes-type
shrinkage estimator like that of Mukherjee and Chatterjee (2008), which would shrink the
estimate from standard logistic regression back to the Symmetric Combination Estimator
when the gene-environment independence assumption is valid.
Supplementary Material
The Supplementary Material includes methodology and theory for the Composite Likelihood
Estimator, the unabridged version of Table 1 with all estimators, and additional simulation
results for model robustness when the disease rate is misspecified or the gene-environment
independence assumption is violated.
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Supplementary Material
S.1 Composite Likelihood Estimator
The estimated composite profile likelihood is just the average of the two symmetric profile
likelihoods
L̂CL(Ω) = {L̂X(Ω) + L̂G(Ω)}/2
=
∑n
i=1log{S(Di, Gi, Xi,Ω)} − 0.5
∑n
i=1log{R̂X(Gi,Ω)} − 0.5
∑n
i=1log{R̂G(Xi,Ω)}.
The estimated score function is thus the average of the two symmetric score functions
ŜCL(Ω) = (ŜX(Ω) + ŜG(Ω))/2
= n−1/2
n∑
i=1
{
SΩ(Di, Gi, Xi,Ω)
S(Di, Gi, Xi,Ω)
−
1
2
R̂XΩ(Xi,Ω)
R̂X(Xi,Ω)
−
1
2
R̂GΩ(Gi,Ω)
R̂G(Gi,Ω)
}
.
Estimate Ω̂CL is calculated by solving ŜCL(Ω) = 0, or equivalently, maximizing L̂CL(Ω).
Following the notation defined previously, we sum eqs. (7) and (8) together instead of
stacking them as in Theorem 1.
Theorem S.1 Suppose that 0 < lim
n→∞
nd/n < 1, and π1 is known. Then
n1/2(Ω̂CL − Ω) = −(ΓX + ΓG)
−1n−1/2
∑n
i=1{ζX∗(Zi,Ω) + ζG∗(Zi,Ω)}+ op(1).
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To calculate the asymptotic variance, write
Σall =
ΣXX ΣXG
ΣGX ΣGG
 = cov
ζX∗(Zi,Ω)ζG∗(Zi,Ω)
 = cov
ζX(Zi,Ω)ζG(Zi,Ω)
 ;
ΣXX =
∑1
d=0(nd/n)cov{ζX∗(Z,Ω)|D = d} =
∑1
d=0(nd/n)cov{ζX(Z,Ω)|D = d};
ΣGG =
∑1
d=0(nd/n)cov{ζG∗(Z,Ω)|D = d} =
∑1
d=0(nd/n)cov{ζG(Z,Ω)|D = d};
ΣXG =
∑1
d=0(nd/n)cov{ζX∗(Z,Ω), ζG∗(Z,Ω)|D = d}
=
∑1
d=0(nd/n)cov{ζX(Z,Ω), ζG(Z,Ω)|D = d} = Σ
T
XG.
Since the Zi are independent and E{ζX∗(Zi,Ω)|Di} = E{ζG∗(Zi,Ω)|Di} = 0, then
n1/2(Ω̂CL − Ω) → Normal(0,ΛCL);
ΣCL =
∑1
d=0(nd/n)cov{ζX∗(Zi,Ω) + ζG∗(Zi,Ω)}
= ΣXX + ΣGG + ΣXG + ΣGX ;
ΛCL = (ΓX + ΓG)
−1ΣCL{(ΓX + ΓG)
−1}T.
The proof of Theorem S.1 follows directly from the proofs of eqs. (7) and (8) and the
properties of M-estimators Ω̂X and Ω̂G.
S.2 Additional Simulations
S.2.1 Unabridged version of Table 1 from Section 3
Table 1 in Section 3 of the main paper reports the results of four estimators: logistic regres-
sion, the SPMLE with known π1, our Symmetric Combination Estimator with known π1,
and our Symmetric Combination Estimator using the rare disease approximation. Table S.2
presents the results of all estimators in 1000 simulations under the simulation settings of
Section 3.1. In addition to logistic regression, four retrospective methods are presented:
the SPMLE (Ω̂X), the SPMLE G (Ω̂G), the Composite Likelihood Estimator (Ω̂CL), and
the Symmetric Combination Estimator (Ω̂Symm). Each retrospective estimator was calcu-
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lated under two conditions: with known π1, and with unknown π1 using the rare disease
approximation.
We see that the rare disease approximation of each retrospective estimator closely matches
the version calculated with known π1. The efficiency of the Composite Likelihood Estimator
is equivalent to that of the SPMLE and its symmetric counterpart, the SPMLE G. The
Symmetric Combination Estimator stands out as markedly more efficient than the other
estimators.
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Table S.2: Results of 1000 simulations as described in Section 3.1, comparing the bias,
coverage, and efficiency of all estimators
βG1 βG2 βG3 βG4 βG5 βX βXG1 βXG2 βXG3 βXG4 βXG5
True 0.18 0.18 0.00 0.18 0.00 0.41 0.26 0.00 0.00 0.26 0.00
Logistic Regression
Bias 0.01 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00
CI(%) 95.2 95.5 94.4 94.7 95.3 95.8 94.5 95.9 94.7 94.6 95.3
SPMLE, known π1
Bias 0.01 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.01
CI(%) 95.4 95.8 94.8 96.1 96.3 95.6 94.6 96.0 94.3 95.6 95.1
MSE Eff 1.32 1.25 1.26 1.32 1.30 1.27 2.08 1.78 1.88 1.95 2.12
SPMLE, rare
Bias 0.02 0.00 0.00 0.01 -0.01 0.02 -0.02 0.00 0.00 -0.01 0.01
CI(%) 95.0 95.7 94.8 95.9 96.4 95.5 94.4 96.0 94.7 95.4 95.7
MSE Eff 1.31 1.26 1.27 1.32 1.30 1.26 2.18 1.89 2.01 2.06 2.27
SPMLE G, known π1
Bias 0.01 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.01
CI(%) 95.0 95.8 94.8 96.1 96.3 95.2 94.8 95.5 94.1 95.6 95.6
MSE Eff 1.35 1.27 1.29 1.34 1.33 1.28 2.12 1.82 1.90 1.98 2.14
SPMLE G, rare
Bias 0.02 0.00 0.00 0.01 -0.01 0.02 -0.02 0.00 0.00 -0.01 0.01
CI(%) 94.9 95.7 94.9 95.9 96.3 94.8 94.1 95.5 94.3 95.0 95.7
MSE Eff 1.35 1.29 1.31 1.35 1.35 1.27 2.25 1.94 2.04 2.10 2.32
Composite Likelihood Estimator, known π1
Bias 0.01 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.01
CI(%) 94.9 95.8 94.9 96.1 96.5 95.4 94.7 95.7 94.4 95.7 95.5
MSE Eff 1.34 1.26 1.28 1.33 1.32 1.28 2.11 1.81 1.90 1.98 2.14
Composite Likelihood Estimator, rare
Bias 0.02 0.00 0.00 0.01 -0.01 0.02 -0.02 0.00 0.00 -0.01 0.01
CI(%) 94.9 95.6 94.9 95.9 96.4 95.2 94.1 95.8 94.8 95.3 95.7
MSE Eff 1.32 1.27 1.29 1.33 1.32 1.27 2.23 1.92 2.03 2.09 2.31
Symmetric Combination Estimator, known π1
Bias 0.00 -0.03 0.00 0.00 -0.01 0.01 -0.03 0.02 0.00 -0.02 0.01
CI∗(%) 96.7 95.7 96.7 96.5 97.8 95.4 94.8 96.7 96.2 96.6 97.2
MSE Eff 1.92 1.71 2.00 1.83 2.05 1.31 2.84 2.51 2.99 2.68 3.34
Symmetric Combination Estimator, rare
Bias 0.01 -0.02 0.00 0.01 -0.01 0.02 -0.05 0.02 0.00 -0.03 0.00
CI∗(%) 96.4 95.7 95.7 96.3 98.1 94.9 94.0 97.0 96.4 95.5 97.5
MSE Eff 1.86 1.71 1.92 1.78 1.95 1.27 2.75 2.66 3.08 2.69 3.58
CI : coverage of a 95% nominal confidence interval, calculated using asymptotic standard error.
CI∗: coverage of a 95% nominal confidence interval, calculated using 200 bootstrap samples.
MSE Eff : mean squared error efficiency when compared to logistic regression.
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S.2.2 Simulation when the disease rate is misspecified
Table S.3 presents the results of a simulation to evaluate the robustness of our method to
misspecification of the population disease rate. A sample of 1000 cases and 1000 controls was
simulated using the same scenario as described in Section 3.1 except the logistic intercept
was modified to yield true population disease rates of 0.05, 0.085, and 0.12. In each instance,
1000 data sets were simulated and the Symmetric Combination Estimator was calculated
with misspecified “known π1 = 0.03” and again using the rare disease approximation.
When using the rare disease approximation, coverage remains near nominal until the true
disease rate reached 0.085, and even then the lowest coverage rate was 91.3% (for interaction
parameter βXG1, which still demonstrated a mean squared error efficiency of 2.51 compared
to logistic regression). When the disease rate was assumed “known π1 = 0.03”, nominal
coverage was seen except when the population disease rate was 0.12. This indicates the
Symmetric Combination Estimator is fairly robust to disease rate misspecification, and even
an imprecise estimate of π1 is likely to be sufficient to conduct a valid analysis.
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Table S.3: Results of simulations as described in Section 3.1, but with population disease
rates (0.05, 0.085, 0.12). For each disease rate, we simulated 1000 data sets and compared
logistic regression, our method with misspecified “known π1 = 0.03”, and our method using
the rare disease approximation.
βG1 βG2 βG3 βG4 βG5 βX βXG1 βXG2 βXG3 βXG4 βXG5
True 0.18 0.18 0.00 0.18 0.00 0.41 0.26 0.00 0.00 0.26 0.00
Disease Rate = 0.05 Logistic Regression
Bias 0.00 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.01
CI(%) 95.8 95.2 95.9 94.7 94.4 95.6 95.7 95.5 95.3 94.8 95.3
Symmetric Combination Estimator, “known π1 = 0.03”
Bias 0.00 -0.03 0.00 0.00 -0.01 0.03 -0.05 0.02 0.00 -0.04 0.01
CI∗(%) 97.6 94.1 97.0 94.8 95.8 95.1 93.7 95.6 96.8 94.8 96.8
MSE Eff 1.84 1.74 2.07 1.69 1.97 1.30 2.61 2.65 3.14 2.37 2.97
Symmetric Combination Estimator, rare
Bias 0.01 -0.02 0.00 0.01 -0.01 0.04 -0.06 0.02 0.00 -0.05 0.00
CI∗(%) 96.9 94.3 97.4 94.4 96.1 94.7 92.2 95.4 96.7 93.4 96.6
MSE Eff 1.75 1.73 2.03 1.60 1.89 1.22 2.48 2.76 3.22 2.25 3.11
Disease Rate = 0.085 Logistic Regression
Bias -0.01 0.01 0.00 0.00 0.00 0.00 0.01 -0.01 0.00 0.00 0.01
CI(%) 94.3 94.9 95.4 94.4 93.5 94.5 94.8 94.0 95.1 95.8 94.5
Symmetric Combination Estimator, “known π1 = 0.03”
Bias 0.00 -0.02 0.00 0.01 -0.01 0.05 -0.07 0.01 0.00 -0.06 0.00
CI∗(%) 96.4 95.2 96.9 95.7 95.7 93.6 92.7 96.0 97.6 92.9 97.1
MSE Eff 1.84 1.81 1.99 1.61 1.90 1.18 2.65 2.81 3.18 2.15 3.20
Symmetric Combination Estimator, rare
Bias 0.01 -0.01 0.00 0.02 -0.01 0.06 -0.08 0.01 0.00 -0.06 0.00
CI∗(%) 96.5 95.8 96.5 95.7 95.3 92.5 91.3 96.1 97.3 91.8 97.1
MSE Eff 1.77 1.81 1.98 1.59 1.86 1.12 2.51 2.91 3.21 2.07 3.30
Disease Rate = 0.12 Logistic Regression
Bias 0.00 0.01 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
CI(%) 94.6 95.4 94.9 94.8 93.7 95.7 94.4 95.9 94.8 94.8 94.8
Symmetric Combination Estimator, “known π1 = 0.03”
Bias 0.00 -0.02 0.00 0.02 -0.01 0.06 -0.08 0.01 0.00 -0.07 0.01
CI∗(%) 96.4 95.6 96.1 94.5 95.6 93.5 89.2 96.4 97.2 89.0 96.9
MSE Eff 1.83 1.71 1.95 1.59 1.86 1.08 2.33 2.80 3.07 1.90 3.02
Symmetric Combination Estimator, rare
Bias 0.02 -0.01 0.00 0.03 -0.01 0.07 -0.10 0.01 0.00 -0.08 0.00
CI∗(%) 95.6 96.1 96.4 94.5 95.1 91.8 86.0 96.6 97.0 87.4 96.0
MSE Eff 1.72 1.72 1.91 1.53 1.79 0.99 2.11 2.95 3.14 1.78 3.11
CI : coverage of a 95% nominal confidence interval, calculated using asymptotic standard error.
CI∗: coverage of a 95% nominal confidence interval, calculated using 200 bootstrap samples.
MSE Eff : mean squared error efficiency when compared to logistic regression.
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S.2.3 Violations of the Gene-Environment Independence Assump-
tion
Table S.4 presents the results of simulations to examine the robustness of our methods
to violations of the gene-environment independence assumption. In these simulations, a
sample of 1000 cases and 1000 controls is simulated with genetic variables as described in
Section 3.1, but the environmental variable is normally distributed with mean αG1, αG2, or
αG3. We set α = 0.032 to induce dependence between X and Gj with R
2 = 0.001. Here
βG = {log(1.2), log(1.2), 0, log(1.2), 0} as in Section 3.1, but βX = log(1.35), and βGX =
{log(1.21), 0, 0, log(1.21), 0}. In each simulation, the logistic intercept was selected to give a
population disease rate of 0.03. In the first simulation, X is correlated with G1, which has
a nonzero main effect and a nonzero interaction; in the second simulation, X is correlated
with G2, which has a nonzero main effect but no interaction effect; in the third simulation,
X is correlated with G3, which has neither main nor interaction effects.
We find that violating the gene-environment independence assumption induces bias in
the estimate of the interaction parameter of the environmental variable and the specific SNP
that is in violation of the gene-environment independence assumption, while the estimated
interaction parameters of the other SNPs are unaffected. When π1 is known, estimates
of the main effects of the SNP that is in violation of the gene-environment independence
assumption are uncompromised.
NOT FOR PUBLICATION SUPPLEMENTARY MATERIAL S.8
Table S.4: Results of simulations violating the gene-environment independence assump-
tion with X ∼ N(0, 0.032Gj) for SNPs (G1, G2, G3). In each instance, we simulated
1000 data sets and compared our method, both with known π1 and using the rare disease
approximation, to logistic regression.
βG1 βG2 βG3 βG4 βG5 βX βXG1 βXG2 βXG3 βXG4 βXG5
True 0.18 0.18 0.00 0.18 0.00 0.30 0.19 0.00 0.00 0.19 0.00
X correlated with G1 Logistic Regression
Bias 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.01
CI(%) 95.3 94.9 95.3 94.3 93.6 95.4 95.5 94.0 94.9 94.1 95.6
Symmetric Combination Estimator, known π1
Bias 0.00 -0.03 0.00 0.00 0.00 -0.01 0.05 0.01 0.00 -0.02 0.00
CI∗(%) 95.8 93.3 95.6 94.3 95.4 94.2 92.5 92.7 95.6 93.5 95.4
MSE Eff 1.31 1.13 1.37 1.26 1.44 1.34 1.91 2.40 2.71 2.41 2.91
Symmetric Combination Estimator, rare
Bias 0.00 -0.03 0.00 0.00 0.00 0.01 0.01 0.01 0.00 -0.03 0.00
CI∗(%) 96.4 92.5 96.3 94.8 95.7 95.5 95.3 93.5 95.8 90.3 95.3
MSE Eff 1.35 1.14 1.47 1.34 1.51 1.43 3.24 2.67 2.96 2.27 3.59
X correlated with G2 Logistic Regression
Bias 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00
CI(%) 94.8 95.1 94.5 94.5 95.3 96.2 94.3 93.4 94.7 95.3 95.2
Symmetric Combination Estimator, known π1
Bias -0.01 -0.02 0.00 0.00 0.00 -0.03 -0.02 0.06 0.00 -0.02 0.00
CI∗(%) 95.6 95.2 95.8 95.5 96.9 93.1 94.2 83.5 95.3 94.1 96.1
MSE Eff 1.33 1.27 1.35 1.32 1.42 1.11 2.79 1.54 2.84 2.63 3.21
Symmetric Combination Estimator, rare
Bias -0.01 -0.02 0.00 0.00 0.00 -0.01 -0.05 0.05 0.00 -0.03 0.00
CI∗(%) 95.8 94.9 95.9 95.1 96.3 96.0 87.7 84.7 95.3 90.3 97.0
MSE Eff 1.34 1.27 1.44 1.35 1.45 1.37 2.41 1.79 3.21 2.43 3.95
X correlated with G3 Logistic Regression
Bias 0.00 0.00 0.00 0.00 -0.01 0.00 0.01 0.00 0.00 0.00 0.01
CI(%) 94.9 94.8 96.0 94.9 95.2 95.0 95.9 95.0 95.6 94.7 94.3
Symmetric Combination Estimator, known π1
Bias -0.01 -0.02 0.01 0.00 -0.01 -0.03 -0.01 0.01 0.05 -0.02 0.00
CI∗(%) 96.0 93.8 96.3 96.4 96.5 92.2 93.5 95.6 89.9 94.0 94.8
MSE Eff 1.33 1.16 1.34 1.25 1.34 1.15 2.56 2.62 1.63 2.33 2.89
Symmetric Combination Estimator, rare
Bias -0.01 -0.03 0.01 0.00 -0.01 -0.01 -0.04 0.01 0.04 -0.03 0.00
CI∗(%) 95.6 93.5 96.3 96.3 96.5 94.4 88.2 96.5 89.1 90.8 95.5
MSE Eff 1.41 1.16 1.35 1.28 1.37 1.39 2.37 3.01 1.78 2.17 3.62
CI : coverage of a 95% nominal confidence interval, calculated using asymptotic standard error.
CI∗: coverage of a 95% nominal confidence interval, calculated using 100 bootstrap samples.
MSE Eff : mean squared error efficiency when compared to logistic regression.
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S.2.4 Simulations with alternative distributions for G and X
Table S.5 presents the results of a simulation in which X and G are both multivariate with
a combination of discrete and continuous components. G1 and G2 are correlated SNPs in
Hardy-Weinberg equilibrium with minor allele frequencies (0.2, 0.3), and G3 has a gamma
distribution with shape = 20 and scale = 20 (to simulate a skewed polygenic risk score).
X1 is binary with frequency 0.5 and X2 has a standard normal distribution. Here βG =
{log(1.2), 0, log(1.38)}, βX = {log(1.5), log(1.14)}, βGX = {log(1.1), 0, 0, 0, 0, 0}, and the
logistic intercept was selected to give a population disease rate of 0.05. Using these settings,
1000 data sets were simulated with 1000 cases and 1000 controls each.
Table S.5: Results of 1000 simulations with multivariate G and X , comparing the bias, coverage,
and efficiency of standard logistic regression to our Symmetric Combination Estimator, both with
known π1 and using the rare disease approximation.
βG1 βG2 βG3 βX1 βX2 βX1G1 βX1G2 βX1G3 βX2G1 βX2G2 βX2G3
True 0.18 0.00 0.32 0.41 0.14 0.10 0.00 0.00 0.00 0.00 0.00
Logistic Regression
Bias 0.01 -0.01 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00
CI(%) 94.4 94.3 95.2 94.6 94.0 95.7 94.7 94.7 94.5 95.4 94.6
Symmetric Combination Estimator, known π1
Bias -0.02 0.00 -0.06 -0.01 -0.02 -0.02 0.00 0.01 0.00 0.00 0.00
CI∗(%) 93.4 94.7 94.9 94.8 96.0 94.1 95.4 96.1 95.8 96.9 96.5
MSE Eff 1.48 1.66 1.61 2.44 2.75 2.22 2.67 2.84 2.90 2.80 3.03
Symmetric Combination Estimator, rare
Bias -0.01 0.00 -0.06 0.00 -0.02 -0.03 0.00 0.01 0.00 0.00 0.00
CI∗(%) 93.3 94.5 95.3 94.8 95.8 94.1 95.6 96.3 95.6 96.9 96.2
MSE Eff 1.54 1.73 1.66 2.60 2.98 2.37 2.98 3.08 3.25 3.07 3.32
CI : coverage of a 95% nominal confidence interval, calculated using asymptotic standard error.
CI∗: coverage of a 95% nominal confidence interval, calculated using 100 bootstrap samples.
MSE Eff : mean squared error efficiency when compared to logistic regression.
S.2.5 Creating the polygenic risk score for the PLCO data analysis
Table S.6 displays the SNPs used in the calculation of the polygenic risk score for the
analysis of the Prostate, Lung, Colorectal and Ovarian cancer screening trial data described
in Section 4.1.
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Table S.6: SNPs involved in creating the polygenic risk score, and their regression coeffi-
cients
RS Number Coefficient
rs11249433 -0.02813492
rs1045485 -0.09307971
rs13387042 -0.26203658
rs4973768 0.08013260
rs10069690 0.06459363
rs10941679 0.09185539
rs889312 -0.00565121
rs17530068 0.09668742
rs2046210 0.09851217
rs1562430 -0.14871719
rs1011970 0.05329783
rs865686 -0.02913340
rs2380205 -0.01821032
rs10995190 -0.04275836
rs2981582 0.14008397
rs909116 0.04955235
rs614367 0.06438418
rs3803662 0.27080105
rs6504950 -0.17586244
rs8170 0.08570773
rs999737 -0.13737833
